Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

No-biopsy Approach for the Diagnosis of Celiac Disease: Definition of Cut-off Points for Different IgA Anti-tissue Transglutaminase Assays

NCT05983978 is registered in ClinicalTrials.gov with Instituto de Investigación Hospital Universitario La Paz as lead sponsor.

NCT NCT05983978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05983978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
No-biopsy Approach for the Diagnosis of Celiac Disease: Definition of Cut-off Points for Different IgA Anti-tissue Transglutaminase Assays
Lead sponsor
Instituto de Investigación Hospital Universitario La Paz
Phase
Observational
Overall status
Recruiting
Start date
January 2, 2023
Completion date
March 31, 2026
Enrollment
150 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease